Outlook Therapeutics Inc (NASDAQ:OTLK)
| 1.51 BATS BZX Real-Time Price As of 3:48pm ET |  -0.005 / -0.33%Today’s Change | 1.19 Today|||52-Week Range 3.27 | +10.66% Year-to-Date |
Latest OTLK News | Press Releases
No recent news for Outlook Therapeutics Inc.
Today’s Trading
| Previous close | 1.51 |
| Today’s open | 1.49 |
| Day’s range | 1.46 - 1.52 |
| Volume | 13,893 |
| Average volume (3 months) | 1,252,188 |
| Market cap | $354.7M |
Data as of 3:48pm ET, 05/25/2022
Growth & Valuation
| Earnings growth (last year) | +48.31% |
| Earnings growth (this year) | +22.86% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 60.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KODKodiak Sciences Inc | +0.17 | +2.60% |
| HRTXHeron Therapeutics I... | -0.04 | -1.11% |
| BTAIBioXcel Therapeutics... | -0.03 | -0.26% |
| MGTXMeiraGTx Holdings PL... | -0.08 | -1.00% |
Data as of 3:52pm ET, 05/25/2022
Financials
| Next reporting date | August 18, 2022 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$53.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Iselin, New Jersey |
Forecasts
